← Open Payments lookup

MATTHEW DECLOUET: Open Payments

NPI 1518342310 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,052 in 130 payments from 19 companies in 2025. Trend: 2023 $1,027 · 2024 $1,896 · 2025 $2,052

Food & beverage: $2,052
CompanyPaymentsAmount
Alkermes, Inc.25$329
Otsuka America Pharmaceutical, Inc.18$278
ABBVIE INC.24$238
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$220
E.R. Squibb & Sons, L.L.C.4$168
Vanda Pharmaceuticals Inc.10$165
Takeda Pharmaceuticals U.S.A., Inc.8$141
Bausch Health US, LLC4$80
Janssen Pharmaceuticals, Inc3$77
Corium, LLC2$54

Products named: ARISTADA, VRAYLAR, CAPLYTA, REXULTI, COBENFY, FANAPT, TRINTELLIX, SPRAVATO.

Industry payments across LA — which companies pay providers there.